PatientSafe Solutions, a San Diego, California-based provider of smart point-of-care mobile solutions and technologies for the healthcare sector, has closed a $20m Series C financing.
The round was led by the Merck Global Health Innovation (GHI) fund, with participation from investors including Camden Partners, TPG Capital, and Psilos Group.
In conjunction with the funding, Max Kahn, an investment principal at Merck GHI, has joined PatientSafe’s Board of Directors.
The company intends to use the capital to increase adoption of its solutions.
Led by Joe Condurso, President and CEO, PatientSafe offers the PatientTouch™ platform, which includes a series of clinical workflow and documentation applications that encompasses barcode positive patient identification (PPID), patient centric care interventions, clinical communications, and collaboration.